Pope & Talbot Inc.
PTBTQ
$0.00
$0.000.00%
| Weiss Ratings | PTBTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | -- | |||
| Risk Index | -- | |||
| Risk Grade | -- | |||
| Reward Grade | -- | |||
| Rating Factors | PTBTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | -- | |||
| Efficiency Index | -- | |||
| Solvency Index | -- | |||
| Total Return Index | -- | |||
| Volatility Index | -- | |||
| Beta / Standard Deviation | PTBTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.60 | |||
| Price History | PTBTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | PTBTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 28, 2024 | |||
| 52-Week High Price (Date) | Mar 28, 2024 | |||
| Valuation | PTBTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 16.00 | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | PTBTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PTBTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 503-228-9161 | |||
| Address | 1500 SW First Avenue Portland, OR 97201 | |||
| Website | -- | |||
| Country | United States | |||
| Year Founded | 1849 | |||
| Profitability | PTBTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 5.61% | |||
| Profit Margin | 1.32% | |||
| Management Effectiveness | PTBTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.35% | |||
| Return on Equity | 12.77% | |||
| Income Statement | PTBTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 841.55M | |||
| Total Revenue (TTM) | 841.55M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -8.23M | |||
| EBITDA (TTM) | 89.06M | |||
| EBIT (TTM) | 47.26M | |||
| Net Income (TTM) | 11.19M | |||
| Net Income Avl. to Common (TTM) | 11.19M | |||
| Total Revenue Growth (Q YOY) | 10.75% | |||
| Earnings Growth (Q YOY) | -96.64% | |||
| EPS Diluted (TTM) | 0.70 | |||
| EPS Diluted Growth (Q YOY) | -94.99% | |||
| Balance Sheet | PTBTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.74M | |||
| Cash Per Share (Q) | $0.17 | |||
| Total Current Assets (Q) | 259.38M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 80.87M | |||
| Current Ratio (Q) | 0.773 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 335.67M | |||
| Total Debt (Q) | -- | |||
| Total Liabilities (Q) | -- | |||
| Total Common Equity (Q) | 80.87M | |||
| Cash Flow | PTBTQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 1.01M | |||
| Cash from Financing (TTM) | -32.63M | |||
| Net Change in Cash (TTM) | -10.14M | |||
| Levered Free Cash Flow (TTM) | -14.57M | |||
| Cash from Operations (TTM) | 18.08M | |||
